A carregar...

Severe hepatic dysfunction is associated with venous thromboembolic events in phase 1 clinical trials

INTRODUCTION: Venous thromboembolic events (VTE) are a significant cause of death in patients with cancer. The incidence of VTE is not well characterized in early phase clinical trials of novel antineoplastic agents, or in hepatic dysfunction studies designed for patients with varying degrees of liv...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Thromb Res
Main Authors: Mansfield, A.S., Tafur, A.J., Vulih, D., Smith, G.L., Harris, P.J., Ivy, S.P.
Formato: Artigo
Idioma:Inglês
Publicado em: 2015
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4679432/
https://ncbi.nlm.nih.gov/pubmed/26493604
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.thromres.2015.10.024
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!